Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

2D Molecular Superconductor to Insulator Transition in the β''-(BEDT-TTF)2[(H2O)(NH4)2M(C2O4)3]·18-crown-6 Series (M = Rh, Cr, Ru, Ir).

Morritt AL, Lopez JR, Blundell TJ, Canadell E, Akutsu H, Nakazawa Y, Imajo S, Martin L.

Inorg Chem. 2019 Aug 19;58(16):10656-10664. doi: 10.1021/acs.inorgchem.9b00292. Epub 2019 Aug 5.

PMID:
31380643
2.

Discovery and structure-activity relationship of imidazolinylindole derivatives as kallikrein 7 inhibitors.

Murafuji H, Muto T, Goto M, Imajo S, Sugawara H, Oyama Y, Minamitsuji Y, Miyazaki S, Murai K, Fujioka H.

Bioorg Med Chem Lett. 2019 Jan 15;29(2):334-338. doi: 10.1016/j.bmcl.2018.11.011. Epub 2018 Nov 8.

PMID:
30522951
3.

Structure-based drug design to overcome species differences in kallikrein 7 inhibition of 1,3,6-trisubstituted 1,4-diazepan-7-ones.

Murafuji H, Sugawara H, Goto M, Oyama Y, Sakai H, Imajo S, Tomoo T, Muto T.

Bioorg Med Chem. 2018 Jul 23;26(12):3639-3653. doi: 10.1016/j.bmc.2018.05.044. Epub 2018 May 26.

PMID:
29884582
4.

Structure-based drug design of 1,3,6-trisubstituted 1,4-diazepan-7-ones as selective human kallikrein 7 inhibitors.

Murafuji H, Sakai H, Goto M, Oyama Y, Imajo S, Sugawara H, Tomoo T, Muto T.

Bioorg Med Chem Lett. 2018 May 1;28(8):1371-1375. doi: 10.1016/j.bmcl.2018.03.011. Epub 2018 Mar 3.

PMID:
29550094
5.

Structure-based design, synthesis, and binding mode analysis of novel and potent chymase inhibitors.

Futamura-Takahashi J, Tanaka T, Sugawara H, Iwashita S, Imajo S, Oyama Y, Muto T.

Bioorg Med Chem Lett. 2018 Jan 15;28(2):188-192. doi: 10.1016/j.bmcl.2017.11.031. Epub 2017 Nov 16.

PMID:
29191554
6.

Bulk Kosterlitz-Thouless Type Molecular Superconductor β″-(BEDT-TTF)2[(H2O)(NH4)2Cr(C2O4)3]·18-crown-6.

Martin L, Lopez JR, Akutsu H, Nakazawa Y, Imajo S.

Inorg Chem. 2017 Nov 20;56(22):14045-14052. doi: 10.1021/acs.inorgchem.7b02171. Epub 2017 Nov 9.

PMID:
29120611
7.

Discovery and structure-activity relationship study of 1,3,6-trisubstituted 1,4-diazepane-7-ones as novel human kallikrein 7 inhibitors.

Murafuji H, Sakai H, Goto M, Imajo S, Sugawara H, Muto T.

Bioorg Med Chem Lett. 2017 Dec 1;27(23):5272-5276. doi: 10.1016/j.bmcl.2017.10.030. Epub 2017 Oct 17.

PMID:
29102227
8.

Molecular conductors from bis(ethylenedithio)tetrathiafulvalene with tris(oxalato)rhodate.

Martin L, Morritt AL, Lopez JR, Nakazawa Y, Akutsu H, Imajo S, Ihara Y, Zhang B, Zhang Y, Guo Y.

Dalton Trans. 2017 Jul 25;46(29):9542-9548. doi: 10.1039/c7dt00881c.

PMID:
28702555
9.

Ambient-pressure molecular superconductor with a superlattice containing layers of tris(oxalato)rhodate enantiomers and 18-crown-6.

Martin L, Morritt AL, Lopez JR, Akutsu H, Nakazawa Y, Imajo S, Ihara Y.

Inorg Chem. 2017 Jan 17;56(2):717-720. doi: 10.1021/acs.inorgchem.6b02708. Epub 2017 Jan 5.

PMID:
28055197
10.

Small-molecule inhibition of PTPRZ reduces tumor growth in a rat model of glioblastoma.

Fujikawa A, Nagahira A, Sugawara H, Ishii K, Imajo S, Matsumoto M, Kuboyama K, Suzuki R, Tanga N, Noda M, Uchiyama S, Tomoo T, Ogata A, Masumura M, Noda M.

Sci Rep. 2016 Feb 9;6:20473. doi: 10.1038/srep20473.

11.

Discovery of novel series of 6-benzyl substituted 4-aminocarbonyl-1,4-diazepane-2,5-diones as human chymase inhibitors using structure-based drug design.

Tanaka T, Sugawara H, Maruoka H, Imajo S, Muto T.

Bioorg Med Chem. 2013 Jul 15;21(14):4233-49. doi: 10.1016/j.bmc.2013.04.079. Epub 2013 May 9.

PMID:
23719288
12.

Synthesis and biological evaluation of truncated α-galactosylceramide derivatives focusing on cytokine induction profile.

Toba T, Murata K, Futamura J, Nakanishi K, Takahashi B, Takemoto N, Tomino M, Nakatsuka T, Imajo S, Goto M, Yamamura T, Miyake S, Annoura H.

Bioorg Med Chem. 2012 May 1;20(9):2850-9. doi: 10.1016/j.bmc.2012.03.025. Epub 2012 Mar 20.

PMID:
22480852
13.

Development of 6-benzyl substituted 4-aminocarbonyl-1,4-diazepane-2,5-diones as orally active human chymase inhibitors.

Maruoka H, Muto T, Tanaka T, Imajo S, Tomimori Y, Fukuda Y, Nakatsuka T.

Bioorg Med Chem Lett. 2007 Jun 15;17(12):3435-9. Epub 2007 Mar 30.

PMID:
17434735
14.

Identification of 6-substituted 4-arylsulfonyl-1,4-diazepane-2,5-diones as a novel scaffold for human chymase inhibitors.

Tanaka T, Muto T, Maruoka H, Imajo S, Fukami H, Tomimori Y, Fukuda Y, Nakatsuka T.

Bioorg Med Chem Lett. 2007 Jun 15;17(12):3431-4. Epub 2007 Mar 16.

PMID:
17419055
15.

Minimum structure requirement of immunomodulatory glycolipids for predominant Th2 cytokine induction and the discovery of non-linear phytosphingosine analogs.

Toba T, Murata K, Nakanishi K, Takahashi B, Takemoto N, Akabane M, Nakatsuka T, Imajo S, Yamamura T, Miyake S, Annoura H.

Bioorg Med Chem Lett. 2007 May 15;17(10):2781-4. Epub 2007 Mar 3.

PMID:
17419054
16.

Mouse mast cell protease-1 cleaves angiotensin I to form angiotensin II.

Saito K, Muto T, Tomimori Y, Imajo S, Maruoka H, Tanaka T, Yamashiro K, Fukuda Y.

Biochem Biophys Res Commun. 2003 Mar 21;302(4):773-7.

PMID:
12646236
17.

[Reactance proneness, collectivism, uniqueness, and resistance to persuasion].

Imajo S.

Shinrigaku Kenkyu. 2002 Oct;73(4):366-72. Japanese.

PMID:
12516187
18.

[Lateral femoral circumflex artery for coronary artery bypass surgery in a patient receiving hemodialysis: report of a case].

Imajo S, Kigawa I, Ito S, Miura S, Naito K, Yokota S, Yamashita Y, Fukuda S, Wanibuchi Y.

Kyobu Geka. 2002 May;55(5):409-12. Japanese.

PMID:
11995323
19.

Synthesis and biological evaluation of new 4-arylpiperidines and 4-aryl-4-piperidinols: dual Na(+) and Ca(2+) channel blockers with reduced affinity for dopamine D(2) receptors.

Annoura H, Nakanishi K, Uesugi M, Fukunaga A, Imajo S, Miyajima A, Tamura-Horikawa Y, Tamura S.

Bioorg Med Chem. 2002 Feb;10(2):371-83.

PMID:
11741786
20.

Discovery of (2S)-1-(4-amino-2,3,5- trimethylphenoxy)-3-[4-[4-(4- fluorobenzyl)phenyl]-1-piperazinyl]-2-propanol dimethanesulfonate (SUN N8075): a dual Na(+) and Ca(2+) channel blocker with antioxidant activity.

Annoura H, Nakanishi K, Toba T, Takemoto N, Imajo S, Miyajima A, Tamura-Horikawa Y, Tamura S.

J Med Chem. 2000 Sep 7;43(18):3372-6. No abstract available.

PMID:
10978184
21.

Substituted 3-phenylsulfonylquinazoline-2,4-dione derivatives as novel nonpeptide inhibitors of human heart chymase.

Fukami H, Imajo S, Ito A, Kakutani S, Shibata H, Sumida M, Tanaka T, Niwata S, Saitoh M, Kiso Y, Miyazaki M, Okunishi H, Urata H, Arakawa K.

Drug Des Discov. 2000;17(1):69-84.

PMID:
10928450
22.
23.

The role of water molecules in the deacylation of acylated structures of class A beta-lactamase.

Ishiguro M, Imajo S.

Drug Des Discov. 1999 Aug;16(2):131-43.

PMID:
10533809
24.

Substituted 3-(phenylsulfonyl)-1-phenylimidazolidine-2,4-dione derivatives as novel nonpeptide inhibitors of human heart chymase.

Niwata S, Fukami H, Sumida M, Ito A, Kakutani S, Saitoh M, Suzuki K, Imoto M, Shibata H, Imajo S, Kiso Y, Tanaka T, Nakazato H, Ishihara T, Takai S, Yamamoto D, Shiota N, Miyazaki M, Okunishi H, Kinoshita A, Urata H, Arakawa K.

J Med Chem. 1997 Jul 4;40(14):2156-63.

PMID:
9216834
25.

5,6-Cis-penems: broad-spectrum anti-methicillin-resistant Staphylococcus aureus beta-lactam antibiotics.

Ishiguro M, Tanaka R, Namikawa K, Nasu T, Inoue H, Nakatsuka T, Oyama Y, Imajo S.

J Med Chem. 1997 Jul 4;40(14):2126-32.

PMID:
9216830
26.

Structure-activity relationships of penem antibiotics: crystallographic structures and implications for their antimicrobial activities.

Tanaka R, Oyama Y, Imajo S, Matsuki S, Ishiguro M.

Bioorg Med Chem. 1997 Jul;5(7):1389-99.

PMID:
9377099
27.

Adsorption and Recovery of Ionic Surfactants by beta-Cyclodextrin Polymer

Murai S, Imajo S, Inumaru H, Takahashi K, Hattori K.

J Colloid Interface Sci. 1997 Jun 15;190(2):488-90.

PMID:
9241195
28.

Modeling study on a hydrolytic mechanism of class A beta-lactamases.

Ishiguro M, Imajo S.

J Med Chem. 1996 May 24;39(11):2207-18.

PMID:
8667364
29.

[The interactive effect of initial position and threat to freedom on psychological reactance].

Imajo S.

Shinrigaku Kenkyu. 1996 Feb;66(6):431-6. Japanese.

PMID:
8935833
30.

Cloning and sequence of the gene encoding a cefotaxime-hydrolyzing class A beta-lactamase isolated from Escherichia coli.

Ishii Y, Ohno A, Taguchi H, Imajo S, Ishiguro M, Matsuzawa H.

Antimicrob Agents Chemother. 1995 Oct;39(10):2269-75.

31.

On the conformation of Phe78 of a chromoprotein antibiotic, neocarzinostatin.

Imajo S, Ishiguro M, Tanaka T, Hirama M, Teplyakov A.

Bioorg Med Chem. 1995 Apr;3(4):429-36.

PMID:
8581426
32.

The specific inhibition of crystal growth of monohydrogen potassium L-tartrate by d-catechin.

Imajo S, Ishiguro M, Ishiguro K, Murashima T, Isoi K, Tanahashi H, Nishino H.

Bioorg Med Chem. 1994 Oct;2(10):1021-7.

PMID:
7773619
33.

A survey of a functional amino acid of class C beta-lactamase corresponding to Glu166 of class A beta-lactamases.

Nukaga M, Tanimoto K, Tsukamoto K, Imajo S, Ishiguro M, Sawai T.

FEBS Lett. 1993 Oct 11;332(1-2):93-8.

34.
36.

A single amino acid substitution converts cytochrome P450(14DM) to an inactive form, cytochrome P450SG1: complete primary structures deduced from cloned DNAS.

Ishida N, Aoyama Y, Hatanaka R, Oyama Y, Imajo S, Ishiguro M, Oshima T, Nakazato H, Noguchi T, Maitra US, et al.

Biochem Biophys Res Commun. 1988 Aug 30;155(1):317-23.

PMID:
3046615
37.

The carcinoembryonic antigen (CEA) contains multiple immunoglobulin-like domains.

Oikawa S, Imajo S, Noguchi T, Kosaki G, Nakazato H.

Biochem Biophys Res Commun. 1987 Apr 29;144(2):634-42.

PMID:
3579935
38.

Chloro-substituent sites and probability of co-planarity in polychlorinated biphenyls in determining uroporphyrin formation in cultured liver cells.

Sassa S, Sugita O, Kappas A, Ohnuma N, Imajo S, Okumura T, Noguchi T.

Biochem J. 1986 Dec 1;240(2):622-3. No abstract available.

39.
40.

Effects of acute and chronic administration of DDVP (dichlorvos) on distribution of brain acetylcholine in rats.

Kobayashi H, Yuyama A, Imajo S, Matsusaka N.

J Toxicol Sci. 1980 Nov;5(4):311-9.

Supplemental Content

Support Center